“Immunotherapy for Recurrent orthostatic cerebral hypo-perfusion syndrome in recurrent COVID-19 infection”, Nep J Neurosci, vol. 18, no. 2, pp. 64–66, Jun. 2021, doi: 10.3126/njn.v18i2.35516.